GLENMARK PHARMACEUTICALS LTD. - Glenmark announces Strategic Development & Licensing Agreement with Celon, Poland for generic Seretide Accuhaler in Europe
23 Oct 2015
Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of Press Release dated October 23, 2015 titled "Glenmark announces Strategic Development & Licensing Agreement with Celon, Poland for generic Seretide Accuhaler in Europe".
Source:
BSE India